MR-Linac: One of One Hundred in Operation Worldwide

RWJBarnabas Health, together with Rutgers Cancer Institute, offers the MR-Linac, a highly advanced imaging and radiation oncology technology, at the Jack & Sheryl Morris Cancer Center, the state’s only freestanding cancer hospital. This unique technology targets complex cancers with extreme precision and accuracy, helping to spare healthy cells from unnecessary radiation.

The MR-Linac at the Morris Cancer Center is one of only 100 operational worldwide and one of just two in New Jersey. A third MR-Linac will be available in New Jersey when the Melchiorre Cancer Center at Cooperman Barnabas Medical Center, an RWJBarnabas Health hospital, opens this year.

The Importance of Cancer Prevention and Screening 

In recognition of Cancer Prevention Awareness Month, Rutgers Cancer Institute and RWJBarnabas Health are reminding individuals to prioritize their health through routine doctors visits, recommended cancer screenings and prevention practices.

The earlier cancer is detected, the sooner treatment can begin - often before symptoms appear. There are guidelines on when to begin cancer screenings, but recommendations can vary based on age, family history, gender, and individual risk factors.

While screening is essential, cancer prevention can also begin long before you step into a doctor’s office. Many lifestyle habits can help reduce cancer risk.

How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients

Liver cancer remains one of the deadliest cancers in the United States, with a five-year survival rate of approximately 22%. People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein.

A study led by Wei-Xing Zong, PhD, in Science Advances found low-protein diets slowed liver tumor growth and cancer death in mice, uncovering a mechanism by which a liver's impaired waste-handling machinery can inadvertently fuel cancer.

The NJ Pediatric Hematology and Oncology Research Center of Excellence (NJ PHORCE)

In honor of International Childhood Cancer Day, Rutgers Cancer Institute and RWJBarnabas Health are shedding light on our goal to advance scientific discovery and reduce the burden of childhood cancer and blood disorders.

Led by Peter Cole, MD, the NJ Pediatric Hematology and Oncology Research Center of Excellence (NJ PHORCE) aims to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy.